Coronary

View the latest content related to this topic

News Conference News STS 2023

Surgeons Argue: STS Data Again Show ISCHEMIA Isn’t Definitive for CABG

The STS registry results bring yet another argument against the downgrade of CABG in the 2021 revascularization guidelines.

Yael L. Maxwell

January 30, 2023

Slides

See all

Presentation AHA 2022

ISCHEMIA-EXTEND: ISCHEMIA Extended Follow-Up Interim Report

Presenter: Judith S. Hochman

November 07, 2022

Presentation AHA 2022

Bivalirudin Plus a High-dose Infusion Versus Heparin Monotherapy in Patients with STEMI Undergoing Primary PCI: The BRIGHT-4 Trial

Presenter: Gregg W. Stone

November 07, 2022

Presentation AHA 2022

Comparison of a Precision Care Strategy With Usual Testing To Guide Management Of Stable Patients With Suspected Coronary Artery Disease

Presenter: Pamela S. Douglas

November 07, 2022

Presentation AHA 2022

Reduction of Lipoprotein(a) With Small Interfering RNA: Results of the OCEAN(a)-DOSE (TIMI 67) Trial

Presenter: Michelle L. O’Donoghue

November 07, 2022

Presentation Cardiovascular Interventions 2022

Intravascular Lithotripsy (IVL): Making Complex PCI Simple

Presenter: Paul S. Teirstein

October 28, 2022

News

See all

News Daily News

P2Y12 Monotherapy Better Than Continued DAPT Even After Complex PCI

By Yael L. Maxwell

February 06, 2023

News Daily News

Celiac Disease and CVD Link Bolstered in UK Biobank

By Todd Neale

February 03, 2023

News Daily News

Sepsis Emerges as Powerful CVD Risk Factor in Large US Analysis

By L.A. McKeown

February 02, 2023

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for January 2023

By Caitlin E. Cox

February 01, 2023

News Daily News

Obesity and CVD: New Review Highlights Where Tools and Meds Fall Short

By Shelley Wood

January 31, 2023

Fellows 2022

May 5

May 08, 2022

CTO 2022

February 24

February 25, 2022

THT 2022

February 1

February 02, 2022

Videos on This Topic

See all

Video Interview

Randomized, Double-Blind Trial of Routine Early Treatment with PCSK-9 inhibitor in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction

Advertisement

Coronary

Surgeons Argue: STS Data Again Show ISCHEMIA Isn’t Definitive for CABG

Slides

ISCHEMIA-EXTEND: ISCHEMIA Extended Follow-Up Interim Report

Bivalirudin Plus a High-dose Infusion Versus Heparin Monotherapy in Patients with STEMI Undergoing Primary PCI: The BRIGHT-4 Trial

Comparison of a Precision Care Strategy With Usual Testing To Guide Management Of Stable Patients With Suspected Coronary Artery Disease

Reduction of Lipoprotein(a) With Small Interfering RNA: Results of the OCEAN(a)-DOSE (TIMI 67) Trial

Intravascular Lithotripsy (IVL): Making Complex PCI Simple

News

P2Y12 Monotherapy Better Than Continued DAPT Even After Complex PCI

Celiac Disease and CVD Link Bolstered in UK Biobank

Sepsis Emerges as Powerful CVD Risk Factor in Large US Analysis

TCTMD’s Top 10 Most Popular Stories for January 2023

Obesity and CVD: New Review Highlights Where Tools and Meds Fall Short

More on This Topic

Upcoming Conferences

CTO 2023

Conference Coverage

Fellows 2022

CTO 2022

THT 2022

Videos on This Topic

Randomized, Double-Blind Trial of Routine Early Treatment with PCSK-9 inhibitor in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction

Advertisement

Coronary

Slides

News

More on This Topic

Upcoming Conferences

Conference Coverage

Videos on This Topic

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content